Chemistry:Liposomal daunorubicin
From HandWiki
Revision as of 02:31, 3 July 2022 by imported>Carolyn (correction)
Liposomal daunorubicin (trade name DaunoXome) is a chemotherapy drug that is FDA approved to treat AIDS related Kaposi's sarcoma. It is also commonly used to treat specific types of leukaemia and non-Hodgkin lymphoma. Liposomal daunorubicin is intravenously administered. It utilizes the liposomal carrier system that provides a favorable pharmacokinetic profile at the site of KS lesions resulting in a 10-fold increase in concentrations compared to that which is achieved with conventional preparations.
See also
External links
- Women&Cancer Magazine Liposomal daunorubicin[yes|permanent dead link|dead link}}]
- Johns Hopkins AIDS Service - New from the Food and Drug Administration (FDA)
- "DaunoXome", Drugs.com explanation
![]() | Original source: https://en.wikipedia.org/wiki/Liposomal daunorubicin.
Read more |